Riskpilot← Back to searchSign inGet full accessCURIDA HOLDING AS
ASActiveOrg 915299679Solbærvegen 5, 2409 ElverumManufacture of pharmaceutical preparations · NACE 2120Est. 20150 employees
Revenue 2024
NOK 13,8M
EBITDA margin
-11.0%
+40% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
NOK 13,7M
+121% vs 2023
| Revenue | NOK 13,8M | — |
| EBITDA | NOK -1,5M | +40% |
| Net profit | NOK 13,7M | +121% |
| Total assets | NOK 244,8M | +19% |
| Equity | NOK 196,1M | +2835% |
| Employees | 0 | — |
Legal name
CURIDA HOLDING AS
Org number
915299679
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
25. april 2015
Share capital
NOK 11 181 091
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap eller styrets leder og daglig leder hver for seg.
Company purpose
Etablere, utvikle og drive næringsvirksomhet, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender. Primært vil selskapet engasjere seg i virksomhet innen produksjon av legemidler, medisinsk utstyr og kosttilskudd.
Address
Solbærvegen 5, 2409 Elverum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 13 830 |
| Staff expenses | −0 | −0 | −0 | −508 | −8 344 |
| EBITDA | −987 | −931 | −15 634 | −2 541 | −1 517 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −987 | −931 | −15 634 | −2 541 | −1 517 |
| Net financials | 4 994 | 6 162 | −162 130 | −64 206 | 19 284 |
| Profit before tax | 4 006 | 5 231 | −177 765 | −66 748 | 17 767 |
| Tax | 881 | 1 151 | −0 | −0 | 4 049 |
| Net profit | 3 125 | 4 081 | −177 765 | −66 748 | 13 718 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 310 928 | 253 204 | 141 398 | 204 858 | 244 767 |
| Equity | 143 737 | 177 808 | 44 | 6 681 | 196 075 |
| Long-term debt | 45 907 | 60 325 | 92 894 | 104 132 | 0 |
| Short-term debt | 121 284 | 15 071 | 48 461 | 94 045 | 48 693 |
| Total debt | 167 191 | 75 396 | 141 354 | 198 177 | 48 693 |
EBITDA margin
-11.0%
This company
15.8%
Market median
-170% vs market
20202024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
7.0%
This company
18.4%
Market median
-62% vs market
20202024
Net profit margin
99.2%
This company
8.1%
Market median
+1125% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AP Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
AA Deputy Member | Deputy Member | 2024 – 2025 |
LR Chief Executive Officer | Chief Executive Officer | 2015 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2025 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (8) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2023 – 2024 | |
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Signet Healthcare Partners Qp Partn | Company | 26.49% | 26.49% | 2024 |
| Company | 24.08% | 24.08% | 2024 | |
| Company | 17.4% | 17.4% | 2024 | |
| Company | 13.5% | 13.5% | 2024 | |
| Company | 10.85% | 10.85% | 2024 | |
Signet Healthcare Partners Accredit | Company | 2.94% | 2.94% | 2024 |
| Company | 2.09% | 2.09% | 2024 | |
| Company | 1.43% | 1.43% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CURIDA HOLDING AS 
SOLBÆRVEGEN EIENDOM ASBoard members of CURIDA HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Per Erik Larsson | Chief Executive Officer | 0 companies |
| Anna Agnieszka Huk | Deputy Member | 0 companies |
| Leif Rune Skymoen | Chief Executive Officer | 0 companies |
| Anne Simensen | Board of Directors | 0 companies |
| Thomas Andreas Schanke Wrede-Holm | Board of Directors | 0 companies |
| Aina Karlstrøm | Board of Directors | 0 companies |
| Jonathan Armitage Arnold | Board of Directors | 0 companies |
| Patrick Hegge Kartevoll | Board of Directors | 0 companies |
| Sverre Foyn Sivertsen | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Chairman | 0 companies |
| Christer Kjos | Board of Directors | 0 companies |
| Stein Egil Valderhaug | Board of Directors | 0 companies |
| Henrik Romero Falch | Board of Directors | 0 companies |
| Nikhil Puri | Board of Directors | 0 companies |
| Tone Væråmoen | Board of Directors | 0 companies |
| Per-Sveno Thoresen | Chairman | 0 companies |
| Øyvind Kongstun Arnesen | Chairman | 0 companies |